• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[智利一家公立医院的肺癌情况]

[Lung cancer at a Chilean public hospital].

作者信息

González L Roberto, Barra M Sebastián, Riquelme U Alejandra, Reyes M Rodrigo, Spencer L M Loreto, Alarcón O Felipe, Seguel S Enrique, Stockins L Aleck, Jadue T Andrés, Saldivia Z Diego, Schaub C AndréS, Alarcón C Emilio

机构信息

Centro Cardiovascular, Hospital Clínico Regional de Concepción: "Dr. Guillermo Grant Benavente", Concepción, Chile.

Facultad de Medicina, Universidad de Concepción, Concepción, Chile.

出版信息

Rev Med Chil. 2022 Jan;150(1):7-16. doi: 10.4067/S0034-98872022000100007.

DOI:10.4067/S0034-98872022000100007
PMID:35856960
Abstract

BACKGROUND

Lung cancer is the world's leading cause of cancer death.

AIM

To describe the clinical, staging and survival characteristics of lung cancer in a public Chilean regional hospital.

MATERIAL AND METHODS

Analysis of a prospective database of a thoracic surgery service, retrieving histologically confirmed lung cancer cases from January 2010 to December 2019 and reviewing their medical records. Cases were re-staged by the TNM-8 system and variables were compared between periods 2010-2014 and 2015-2019.

RESULTS

We retrieved 551 lung cancer cases, 333 (60 %) men, with a mean age of 65 years. Distant metastases were found in 72% of cases (excluding lymphatic metastases). Of the non-small cell lung cancers (NSCLC), 50 (10%) cases were in stage I, 18 (4%) in stage II, 81 (16%) in stage III and 347 (70%) in stage IV. Global five-year survival was 18%, 20% for NSCLC, 71% for excised NSCLC, 8% for non-excised NSCLC, 88% for stage I and 92% for subgroup IA. Resective surgery was performed in 81 (14%) cases. When comparing 2010-2014 and 2015-2019 periods, the frequency of resective surgery increased from 7% to 20%.

CONCLUSIONS

The diagnosis of lung cancer was frequently made in advanced stages. There was a significant increase in early diagnosis and frequency of surgeries with curative intent in the second observation period.

摘要

背景

肺癌是全球癌症死亡的主要原因。

目的

描述智利一家公立地区医院肺癌的临床、分期和生存特征。

材料与方法

分析胸外科前瞻性数据库,检索2010年1月至2019年12月经组织学确诊的肺癌病例并查阅其病历。病例按TNM-8系统重新分期,并比较2010 - 2014年和2015 - 2019年期间的变量。

结果

我们检索到551例肺癌病例,其中男性333例(60%),平均年龄65岁。72%的病例发现有远处转移(不包括淋巴转移)。在非小细胞肺癌(NSCLC)中,50例(10%)为I期,18例(4%)为II期,81例(16%)为III期,347例(70%)为IV期。总体五年生存率为18%,NSCLC为20%,切除的NSCLC为71%,未切除的NSCLC为8%,I期为88%,IA亚组为92%。81例(14%)病例进行了根治性手术。比较2010 - 2014年和2015 - 2019年期间,根治性手术的频率从7%增加到20%。

结论

肺癌诊断多在晚期。在第二个观察期,早期诊断和根治性手术频率显著增加。

相似文献

1
[Lung cancer at a Chilean public hospital].[智利一家公立医院的肺癌情况]
Rev Med Chil. 2022 Jan;150(1):7-16. doi: 10.4067/S0034-98872022000100007.
2
Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.性别相关的非小细胞肺癌分期;第八版肿瘤、淋巴结、转移分期系统中性别差异的影响分析。
Clin Lung Cancer. 2018 Nov;19(6):e933-e944. doi: 10.1016/j.cllc.2018.08.004. Epub 2018 Aug 22.
3
Patients with localized non-small cell lung cancer miss out on curative surgery with distance from specialist care.局部非小细胞肺癌患者因距离专科医疗服务较远而无法接受根治性手术。
ANZ J Surg. 2015 Sep;85(9):658-63. doi: 10.1111/ans.12855. Epub 2014 Sep 29.
4
Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.可切除非小细胞肺癌患者的常规术前脑部 CT-英国一家三级胸科中心的十年经验。
Lung Cancer. 2018 Aug;122:195-199. doi: 10.1016/j.lungcan.2018.06.014. Epub 2018 Jun 10.
5
[Cases of death after surgery for pathologic stage I non-small cell lung cancer].[病理I期非小细胞肺癌手术后的死亡病例]
Kyobu Geka. 2002 Feb;55(2):110-5.
6
The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.国际肺癌研究协会分期项目:手术治疗的非小细胞肺癌的预后因素及病理TNM分期
J Thorac Oncol. 2009 Jul;4(7):792-801. doi: 10.1097/JTO.0b013e3181a7716e.
7
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.淋巴结大小可预测非小细胞肺癌患者在诊断时的无症状脑转移。
Clin Lung Cancer. 2019 Jan;20(1):e107-e114. doi: 10.1016/j.cllc.2018.09.014. Epub 2018 Sep 24.
8
Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.具有治愈意图的非小细胞肺癌切除术后病理淋巴结分期质量与生存的相关性研究。
JAMA Oncol. 2018 Jan 1;4(1):80-87. doi: 10.1001/jamaoncol.2017.2993.
9
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.早期表皮生长因子受体阳性非小细胞肺癌切除术后复发的临床病理和分子肿瘤特征的相关性研究。
JAMA Netw Open. 2021 Nov 1;4(11):e2131892. doi: 10.1001/jamanetworkopen.2021.31892.
10
A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.荷兰基于人群的 T3N0 非小细胞肺癌手术切除患者结局的研究,采用 TNM-7 和 TNM-8 分期;分期算法中纳入组织学的变化依据和论证。
J Thorac Oncol. 2019 Mar;14(3):459-467. doi: 10.1016/j.jtho.2018.10.164. Epub 2018 Nov 5.

引用本文的文献

1
Budget impact analysis of neoadjuvant nivolumab for non-small cell lung cancer in the Chilean public healthcare system: An exploratory economic assessment.智利公共医疗系统中用于非小细胞肺癌的新辅助纳武单抗的预算影响分析:一项探索性经济评估。
Clin Transl Oncol. 2025 Aug;27(8):3375-3385. doi: 10.1007/s12094-025-03872-7. Epub 2025 Mar 2.
2
Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the Chilean health care system.在智利医疗体系下,比较 durvalumab 巩固治疗与放化疗后不进行巩固治疗用于 III 期非小细胞肺癌的预算影响分析。
PLoS One. 2024 Jul 26;19(7):e0307473. doi: 10.1371/journal.pone.0307473. eCollection 2024.